Drug intelligence / Profile preview

methcathinone

Development stage
Discontinued
Modality
Small Molecules
Administration
Oral, Intranasal, Intravenous, Inhalation
01

Overview

Methcathinone is a synthetic stimulant drug and a structural analogue of methamphetamine and cathinone. It is classified as a synthetic cathinone and is often clandestinely manufactured from readily available chemicals[1][2][3]. Methcathinone acts as a potent central nervous system stimulant with effects similar to amphetamines and cocaine. Its primary mechanism involves inhibition of monoamine reuptake (dopamine, norepinephrine, serotonin) by acting as a substrate for their respective transporters[5][6]. This leads to increased synaptic concentrations of these neurotransmitters. Methcathinone produces euphoria, increased alertness and energy, appetite suppression, enhanced empathy and sociability; adverse effects include hypertension, tachycardia, bruxism (jaw clenching), insomnia or binge use patterns followed by depression or sleep[2][5]. Chronic high-dose use can result in acute mental confusion or psychosis that typically resolves after cessation. The drug has no approved medical uses; it is primarily encountered as an illicit recreational substance.

Other names
catjeffcatnipM-Katkatintash
02

Targets

DAT (Dopamine plasma membrane transport protein)NET (Norepinephrine Transporter)SERT (Sodium-dependent serotonin transporter)

Beyond the preview

Go deeper on methcathinone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on methcathinone.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call